• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday

    9/23/22 3:42:10 AM ET
    $AGRI
    $ALBO
    $AMBO
    $ANTX
    Metal Fabrications
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGRI alert in real time by email

    Gainers

    • Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) gained 105.9% to close at $0.44 after the company received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol. The company also announced the effectiveness of its 1-for-15 reverse split on Sept. 23.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) gained 46.4% to close at $0.3550.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) jumped 44.7% to close at $0.3118 on Thursday.
    • ShiftPixy, Inc. (NASDAQ:PIXY) shares gained 39% to close at $18.98. ShiftPixy, on Wednesday, announced pricing of $5 million private placement.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) climbed 35.7% to close at $51.06.
    • Cano Health, Inc. (NYSE:CANO) jumped 32.2% to settle at $8.34 following a WSJ report suggesting Humana and others may be potential buyers of Cano Health.
    • iSpecimen Inc. (NASDAQ:ISPC) rose 26.5% to close at $1.91. iSpecimen named Chief Financial Officer, Tracy Curley, as interim CEO.
    • Heliogen, Inc. (NASDAQ:HLGN) surged 23.6% to settle at $2.15.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) gained 23.5% to close at $1.63. Sonnet BioTherapeutics recently announced progress in Phase 1 dose-escalation trials of SON-1010.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) jumped 22.9% to settle at $0.2090.
    • Talkspace, Inc. (NASDAQ:TALK) rose 22.4% to close at $1.02.
    • Amprius Technologies, Inc. (NASDAQ:AMPX) gained 22.1% to settle at $11.54.
    • HeartBeam, Inc. (NASDAQ:BEAT) shares rose 20.9% to close at $1.91 after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
    • AN2 Therapeutics, Inc. (NASDAQ:ANTX) gained 17.8% to close at $11.20.
    • Freshpet, Inc. (NASDAQ:FRPT) jumped 15.9% to settle at $45.47 following a report suggesting Jana Partners, which reportedly owns a 10% stake in the company, is pushing the company to make changes to boost the stock price, including a potential sale.
    • Forza X1, Inc. (NASDAQ:FRZA) rose 15.5% to settle at $2.53.
    • United Maritime Corporation (NASDAQ:USEA) climbed 15.1% to close at $1.75. United completed stock buyback of $3 million and initiated additional $3 million stock buyback plan.
    • SoundHound AI, Inc. (NASDAQ:SOUN) gained 13.7% to settle at $3.24.
    • Siyata Mobile Inc. (NASDAQ:SYTA) jumped 12.8% to close at $0.4262 after the company announced that it has received a purchase order from a federal government contractor who will provide Uniden cellular booster kits and accessories to the U.S. Navy.
    • Rain Therapeutics Inc. (NASDAQ:RAIN) gained 12.8% to settle at $6.63.
    • Reading International, Inc. (NASDAQ:RDIB) gained 12.5% to close at $19.14.
    • CareMax, Inc. (NASDAQ:CMAX) rose 12.2% to close at $7.25.
    • Kalera Public Limited Company (NASDAQ:KAL) gained 11.8% to settle at $1.37.
    • MSP Recovery, Inc. (NASDAQ:MSPR) jumped 11.7% to close at $1.2850.
    • Albireo Pharma, Inc. (NASDAQ:ALBO) rose 11% to close at $19.27. Albireo announced $115M royalty monetization agreement with Sagard.
    • Cosmos Holdings Inc. (NASDAQ:COSM) gained 10.8% to close at $0.2599 after Virax Biolabs announced that it has entered into a distribution agreement to market Monkeypox Virus Real-Time PCR Detection Kits with Cosmos.
    • Eliem Therapeutics, Inc. (NASDAQ:ELYM) gained 10.6% to close at $3.44.
    • Electra Battery Materials Corporation (NASDAQ:ELBM) surged 9.7% to settle at $3.29 after the company and LG Energy Solution signed a three-year cobalt supply agreement.
    • Zenvia Inc. (NASDAQ:ZENV) rose 9.6% to close at $1.60.
    • Rumble Inc. (NASDAQ:RUM) gained 9% to close at $13.25.
    • Virtu Financial, Inc. (NASDAQ:VIRT) rose 8.6% to close at $23.24 after it was reported the SEC is poised to let Wall Street keep payment-for-order-flow deals.
    • Gogoro Inc. (NASDAQ:GGR) gained 8.2% to settle at $4.90.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) shares gained 7.9% to close at $3.28 after the company announced it has entered into a distribution agreement to market Monkeypox Virus Real-Time PCR Detection Kits with Cosmos Holdings.
    • Li Auto Inc. (NASDAQ:LI) gained 4.9% to close at $24.23 after the company announced it will host a launch event to unveil the Li L8 on Friday, September 30, 2022, ahead of schedule.
    • Trip.com Group Limited (NASDAQ:TCOM) jumped 4.8% to close at $25.60 after the company reported Q2 financial results.
    • Deutsche Bank Aktiengesellschaft (NYSE:DB) rose 3.1% to close at $8.87. Deutsche Bank said its New York Branch, Deutsche Bank New York, and its affiliate Deutsche Bank Trust Company Americas have raised their prime lending from 5.50% to 6.25%.

     

    Losers

    • Loop Media, Inc. (NYSE:LPTV) shares dipped 46.2% to settle at $4.95 on Thursday after the company announced the pricing of its initial public offering of 2.4 million shares at $5 per share. The company also announced the listing of its shares on the NYSE American.
    • Top Ships Inc. (NASDAQ:TOPS) shares fell 44.1% to close at $0.12 on Thursday after the company announced a 1-for-20 reverse stock split.
    • ECMOHO Limited (NASDAQ:MOHO) fell 42.7% to close at $0.0999 after jumping over 50% on Wednesday.
    • Pintec Technology Holdings Limited (NASDAQ:PT) shares fell 28.8% to close at $0.42 on Thursday.
    • Schmitt Industries, Inc. (NASDAQ:SMIT) fell 27.6% to close at $2.2750.
    • SOBR Safe, Inc. (NASDAQ:SOBR) dipped 27.6% to close at $1.73, possibly selling off after the stock surged Tuesday following a report suggesting The National Transportation Safety Board is recommending that NHTSA require passive alcohol-detection systems.
    • Motorsport Games Inc. (NASDAQ:MSGM) fell 26.5% to close at $0.6130.
    • MediWound Ltd. (NASDAQ:MDWD) fell 22.9% to close at $1.35 after the company announced concurrent registered direct and private placement offerings priced at-the-market of roughly $30 million.
    • WaveDancer, Inc. (NASDAQ:WAVD) dropped 22.7% to close at $0.75.
    • Apexigen, Inc. (NASDAQ:APGN) dipped 19.9% to settle at $5.04.
    • Nano Labs Ltd (NASDAQ:NA) fell 19.9% to close at $3.8954.
    • PaxMedica, Inc. (NASDAQ:PXMD) dropped 19.9% to close at $2.33.
    • Cepton, Inc. (NASDAQ:CPTN) fell 19.1% to close at $1.69. Cepton recently announced a collaboration with NVIDIA to add Cepton lidar models into NVIDIA DRIVE Sim.
    • Nauticus Robotics, Inc. (NASDAQ:KITT) declined 18.9% to close at $5.16. Schlumberger B.V. recently disclosed 15.5% passive stake in Nauticus Robotics.
    • ERYTECH Pharma S.A. (NASDAQ:ERYP) fell 18.9% to close at $0.60.
    • Ambow Education Holding Ltd. (NYSE:AMBO) declined 18.8% to settle at $0.3003.
    • Helius Medical Technologies, Inc. (NASDAQ:HSDT) dropped 17.7% to settle at $0.36.
    • NuCana plc (NASDAQ:NCNA) fell 16.8% to settle at $1.14. Jefferies maintained NuCana with a Buy and lowered the price target from $21 to $3.
    • Nutex Health, Inc. (NASDAQ:NUTX) declined 16.7% to close at $1.50.
    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) declined 16.4% to close at $1.48. AgriFORCE announced purchase agreement with Stronghold Power Systems to acquire land for Coachella Campus.
    • Luminar Technologies, Inc. (NASDAQ:LAZR) fell 16.1% to close at $7.86 after Northland Capital downgraded the stock from Outperform to Market Perform and lowered its price target from $13 to $10.
    • S&W Seed Company (NASDAQ:SANW) fell 15.8% to close at $0.7112.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) dropped 15.6% to settle at $3.03.
    • Altamira Therapeutics Ltd. (NASDAQ:CYTO) fell 14.5% to close at $0.27.
    • Scholar Rock Holding Corporation (NASDAQ:SRRK) dropped 14.5% to settle at $7.42. Scholar Rock named Jay Backstrom, M.D., M.P.H., to be next Chief Executive Officer.
    • CureVac N.V. (NASDAQ:CVAC) declined 14.1% to close at $7.55.
    • HilleVax, Inc. (NASDAQ:HLVX) dropped 14% to close at $17.18.
    • Stitch Fix, Inc. (NASDAQ:SFIX) fell 13.9% to settle at $4.1750. Barclays maintained Stitch Fix with an Equal-Weight and lowered the price target from $7 to $5.
    • NerdWallet, Inc. (NASDAQ:NRDS) declined 13.6% to settle at $9.61.
    • Novavax, Inc. (NASDAQ:NVAX) fell 13.3% to settle at $22.44. JP Morgan downgraded Novavax from Neutral to Underweight and lowered the price target from $132 to $27.
    • Zai Lab Limited (NASDAQ:ZLAB) fell 13% to close at $37.33.
    • Sonder Holdings Inc. (NASDAQ:SOND) dropped 13% to close at $1.47.
    • Immuneering Corporation (NASDAQ:IMRX) declined 13% to close at $10.54.
    • Outset Medical, Inc. (NASDAQ:OM) fell 12.6% to close at $14.74.
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) fell 12.6% to close at $2.30.
    • Desktop Metal, Inc. (NYSE:DM) fell 12.5% to close at $2.59.
    • Carvana Co. (NYSE:CVNA) dropped 12% to settle at $26.97.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares fell 10.7% to close at $3.94. The company on Monday announced it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments for $28 million in stock.
    • Aspen Aerogels, Inc. (NYSE:ASPN) declined 10.4% to close at $10.73.
    • fuboTV Inc. (NYSE:FUBO) dipped 10.3% to close at $3.92.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) fell 10.1% to close at $3.58.
    • Steelcase Inc. (NYSE:SCS) fell 10.1% to close at $8.31 after the company reported worse-than-expected Q2 sales results and issued Q3 revenue guidance below estimates.
    • iHuman Inc. (NYSE:IH) dropped 9% to close at $1.8101 following Q2 results.
    • Jiuzi Holdings, Inc. (NASDAQ:JZXN) fell 7.7% to close at $0.38.
    • Avis Budget Group, Inc. (NASDAQ:CAR) fell 7.6% to close at $138.95.
    • China Pharma Holdings, Inc. (NYSE:CPHI) shares fell 7.4% to close at $0.1430.
    • Impinj, Inc. (NASDAQ:PI) declined 7.4% to close at $85.69.
    • DBV Technologies S.A. (NASDAQ:DBVT) fell 7.2% to close at $2.05 after the company announced the FDA has placed a partial clinical hold on its VITESSE phase 3 clinical study.
    • KB Home (NYSE:KBH) fell 5.1% to close at $26.60. KB Home reported better-than-expected earnings for its third quarter. The company also said it sees Q4 housing revenue of $1.95 billion to $2.05 billion.
    • Darden Restaurants, Inc. (NYSE:DRI) dropped 4.4% to settle at $125.45 after the company reported worse-than-expected Q1 sales results.
    Get the next $AGRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRI
    $ALBO
    $AMBO
    $ANTX

    CompanyDatePrice TargetRatingAnalyst
    Li Auto Inc.
    $LI
    3/17/2026$19.00Buy → Neutral
    Goldman
    Heartbeam Inc.
    $BEAT
    3/16/2026$8.00Buy → Speculative Buy
    The Benchmark Company
    NerdWallet Inc.
    $NRDS
    3/13/2026Equal-Weight → Underweight
    Morgan Stanley
    KB Home
    $KBH
    3/4/2026$65.00Hold
    Truist
    Freshpet Inc.
    $FRPT
    2/24/2026$90.00Equal-Weight → Overweight
    Morgan Stanley
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Impinj Inc.
    $PI
    2/6/2026$112.00Outperform → In-line
    Evercore ISI
    FuboTV Inc.
    $FUBO
    2/5/2026$3.00Neutral → Buy
    Seaport Research Partners
    More analyst ratings

    $AGRI
    $ALBO
    $AMBO
    $ANTX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer-Healthcare Montgomery Pamela W. bought $7,021 worth of shares (79 units at $88.87), increasing direct ownership by 3% to 2,758 units (SEC Form 4)

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/16/26 3:02:43 PM ET
    $NUTX
    Real Estate

    Director George Walter N. bought $49,795 worth of shares (630 units at $79.04), increasing direct ownership by 1% to 47,157 units (SEC Form 4)

    4 - Freshpet, Inc. (0001611647) (Issuer)

    2/26/26 4:07:13 PM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    Large owner Pentwater Capital Management Lp bought $40,060,075 worth of shares (425,000 units at $94.26) and exercised 85,200 in-the-money shares at a strike of $130.46 (SEC Form 4)

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 9:40:48 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    $AGRI
    $ALBO
    $AMBO
    $ANTX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for NEXOBRID issued to MEDIWOUND, LTD

    Submission status for MEDIWOUND, LTD's drug NEXOBRID (SUPPL-10) with active ingredient ANACAULASE-BCDB has changed to 'Approval' on 08/15/2024. Application Category: BLA, Application Number: 761192, Application Classification:

    8/16/24 4:36:54 AM ET
    $MDWD
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGRI
    $ALBO
    $AMBO
    $ANTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

    Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability supported by gross margins of approximately 75%NOOR Collagen alone is projected to generate more than $12 million in annualized revenue Strong growth expected ahead, driven by organic progress and M&A pipeline including a recent LOI to acquire an $11.5 million pharmacy distribution network Holds valuable non-core strategic real estate and digital assets with an estimated fair market value exceeding $18 million, providing meaningful balance sheet flexibilityEvaluating potential monetization

    3/19/26 12:45:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Grove Collaborative and Oceanic Preservation Society Launch The Unplastic Shop to Help Consumers Reduce Plastic Exposure at Home

    Launched March 16, the new collection features ~500 vetted products and education to support practical, everyday swaps. Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic neutral retailer, leading sustainable consumer products company, Certified B Corporation, and Public Benefit Corporation, today announced a new partnership with Oceanic Preservation Society (OPS) to launch The Unplastic Shop—an education-led, curated shopping destination designed to help customers reduce plastic exposure where it matters most in everyday routines. For decades, plastic has been framed primarily as an environmental issue. Microplastics and certain chemica

    3/19/26 12:28:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    NerdWallet Named "Financial Planning Platform of the Year" in 2026 FinTech Breakthrough Awards Program

    LOS ANGELES, March 19, 2026 (GLOBE NEWSWIRE) -- FinTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global FinTech market, today announced that NerdWallet, Inc., which provides trustworthy financial guidance to consumers and small and mid-sized businesses (SMBs), has been selected as winner of the "Financial Planning Platform of the Year" award in the 10th annual FinTech Breakthrough Awards program. Marking its 10-year anniversary, the FinTech Breakthrough Awards program continues its mission of honoring the innovators that are redefining the future of financial services through breakthrough technology,

    3/19/26 10:00:00 AM ET
    $NRDS
    EDP Services
    Technology

    $AGRI
    $ALBO
    $AMBO
    $ANTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Li Auto downgraded by Goldman with a new price target

    Goldman downgraded Li Auto from Buy to Neutral and set a new price target of $19.00

    3/17/26 7:56:17 AM ET
    $LI
    Auto Manufacturing
    Industrials

    HeartBeam downgraded by The Benchmark Company with a new price target

    The Benchmark Company downgraded HeartBeam from Buy to Speculative Buy and set a new price target of $8.00

    3/16/26 8:51:28 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    NerdWallet downgraded by Morgan Stanley

    Morgan Stanley downgraded NerdWallet from Equal-Weight to Underweight

    3/13/26 8:45:52 AM ET
    $NRDS
    EDP Services
    Technology

    $AGRI
    $ALBO
    $AMBO
    $ANTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Pentwater Capital Management Lp

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    3/19/26 11:03:48 AM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    SEC Form 3 filed by new insider Lu Wenbin

    3 - iHuman Inc. (0001814423) (Issuer)

    3/18/26 5:59:01 PM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form 3 filed by new insider Dai Peng

    3 - iHuman Inc. (0001814423) (Issuer)

    3/18/26 5:58:55 PM ET
    $IH
    Other Consumer Services
    Real Estate

    $AGRI
    $ALBO
    $AMBO
    $ANTX
    SEC Filings

    View All

    SEC Form 6-K filed by Electra Battery Materials Corporation

    6-K - Electra Battery Materials Corp (0001907184) (Filer)

    3/19/26 8:01:47 AM ET
    $ELBM
    Industrial Machinery/Components
    Miscellaneous

    Darden Restaurants Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DARDEN RESTAURANTS INC (0000940944) (Filer)

    3/19/26 7:06:37 AM ET
    $DRI
    Restaurants
    Consumer Discretionary

    SEC Form SCHEDULE 13D filed by NuCana plc

    SCHEDULE 13D - NuCana plc (0001709626) (Subject)

    3/18/26 6:39:36 PM ET
    $NCNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRI
    $ALBO
    $AMBO
    $ANTX
    Financials

    Live finance-specific insights

    View All

    Darden Restaurants Reports Fiscal 2026 Third Quarter Results; Declares Quarterly Dividend; And Updates Fiscal 2026 Financial Outlook

    ORLANDO, Fla., March 19, 2026 /PRNewswire/ -- Darden Restaurants, Inc. (NYSE:DRI) today reported its financial results for the third quarter ended February 22, 2026. Third Quarter 2026 Financial Highlights, Comparisons Versus Same Fiscal Quarter Last YearTotal sales increased 5.9% to $3.3 billion, driven by a blended same-restaurant sales1 increase of 4.2% and sales from 31 net new restaurantsSame-restaurant sales:Consolidated Darden14.2 %Olive Garden3.2 %LongHorn Steakhouse7.2 %Fine Dining2.1 %Other Business13.9 %Reported diluted net earnings per share from continuing operations were $2.68Excluding $0.05 of closed restaurant and other costs related to the exploration of strategic alternativ

    3/19/26 7:00:00 AM ET
    $DRI
    Restaurants
    Consumer Discretionary

    Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026

    CAMBRIDGE, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with high unmet need, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, and provide a business update on Thursday, March 26, 2026, after market close. The Company does not intend to host a conference call. About Spero TherapeuticsSpero Therapeutics, headquartered in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare di

    3/18/26 4:05:00 PM ET
    $SPRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Scholar Rock (NASDAQ:SRRK, the "Company")) today announced that the company granted inducement equity awards covering an aggregate of 60,655 shares of its common stock to five newly hired employees, consisting of inducement stock options to purchase an aggregate of 24,506 shares of common stock and inducement restricted stock units, covering an aggregate of 36,149 shares of its common stock. The awards are subject to all terms and conditions and other provisions set forth in the Company's 2022 Inducement Equity Plan (the "Plan") and the award agreements thereunder. The Plan, initially adopted by the Company's board of directors on June 16, 2022, and as amended from time to time, is used

    3/13/26 4:15:00 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGRI
    $ALBO
    $AMBO
    $ANTX
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

    Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability supported by gross margins of approximately 75%NOOR Collagen alone is projected to generate more than $12 million in annualized revenue Strong growth expected ahead, driven by organic progress and M&A pipeline including a recent LOI to acquire an $11.5 million pharmacy distribution network Holds valuable non-core strategic real estate and digital assets with an estimated fair market value exceeding $18 million, providing meaningful balance sheet flexibilityEvaluating potential monetization

    3/19/26 12:45:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    CISO Global Appoints Dhaval Damania as EVP of Cybersecurity & IT

    Experienced AI and enterprise IT operations leader joins Company to accelerate scalable growth, strengthen security architecture, and advance next-generation cyber software innovation Scottsdale, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Dhaval Damania as Executive Vice President of Cybersecurity & IT. This appointment reinforces its continued commitment to operational excellence, innovation, and scalable growth across its next-generation cybersecurity software portfolio. In this role, Damania will lead CISO Global's

    2/23/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    $AGRI
    $ALBO
    $AMBO
    $ANTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13D filed by Sonder Holdings Inc.

    SC 13D - Sonder Holdings Inc. (0001819395) (Subject)

    11/27/24 4:15:36 PM ET
    $SOND
    Hotels/Resorts
    Consumer Discretionary

    SEC Form SC 13G filed by Sonder Holdings Inc.

    SC 13G - Sonder Holdings Inc. (0001819395) (Subject)

    11/27/24 4:12:28 PM ET
    $SOND
    Hotels/Resorts
    Consumer Discretionary